Business
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
Early Post-Clearance Momentum Signals Accelerated Hospital Adoption of Advanced RoboticsHINGHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that Tampa General Hospital has become the first health system in Florida to adopt LIBERTY, marking another important milestone following the Company’s recent FDA 510(k) clearance. Microbot believes that this reflects early po
About this update from Microbot Medical Inc.
[{"type":"image","alt":"Microbot Medical Inc.","displaySize":"","headline":null,"caption":"Microbot Medical Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":127,"url":"https://media.zenfs.com/en/globenewswire.com/9626a8786202041757b3030226d69d16"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8sc4mubv858DmIYRrwJwfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/9626a8786202041757b3030226d69d16","width":300,"height":127}},"lazy":false},{"type":"text","content":"Early Post-Clearance Momentum Signals Accelerated Hospital Adoption of Advanced Robotics","length":88,"tagName":"p"},{"type":"text","content":"HINGHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that Tampa General Hospital has become the first health system in Florida to adopt LIBERTY, marking another important milestone following the Company’s recent FDA 510(k) clearance. Microbot believes that this reflects early post-clearance momentum for LIBERTY and highlights growing institutional readiness for advanced robotic solutions in peripheral endovascular procedures. The U.S. market for peripheral endovascular procedures encompasses approximately 2.5 million procedures annually, representing a significant and expanding clinical and commercial opportunity.","length":754,"tagName":"p"},{"type":"text","content":"“As the first health system in Florida to adopt LIBERTY, we are advancing our commitment to leading-edge technology that has the potential to meaningfully transform how care is delivered,” said Dr. Jean Bismuth, Division Chief of Vascular Surgery for University of South Florida Morsani College of Medicine and Medical Director, TGH Heart & Vascular Institute. “LIBERTY brings sophisticated robotic capabilities to the endovascular space, allowing us to extend advanced innovation directly to our patients. It also has the potential to protect the long-term health of our physicians by addressing growing concerns around radiation safety and ergonomic strain. Within a collaborative model at TGH, we believe it is imperative that robotics ultimately be adopted as a programmatic platform across multiple specialties, including interventional cardiology, electrophysiology, and in...